New insights in the costs of medicines

Because Fair Medicine wants to introduce a new business model for the pharmaceutical industry, we try to analyse the costs of making medicines the classical way. A report of Gupta Strategists, gives more insights.

More transparency is needed

FM researcher Simon van der Schans pleads for more transparency when it comes to drugs prices. ‘The cost structure in the pharmaceutical sector is much too complex.’

 

Fair Medicine aims for Rediscovery

Frans-Joseph Sinjorgo (59) is the leader of Fair Medicine’s Rediscovery project, which aims to use the active ingredients from ‘older’ drugs to develop new applications.

Fair Medicine, how we work

Working together to make good medicines for a fair price

 

 

Better medicines for a fair price

Fair Medicine produces medicines according to a new business model, in which transparency and affordability come first. According to Cees Smit, author of ‘The Power of the Patient’, Fair Medicine can function as a ‘lever’.

Better medicines for a fair price

Fair Medicine produces medicines according to a new business model, in which transparency and affordability come first.. Professor Carla Hollak thinks it is ‘a great thing’ that Fair Medicine gives physicians more influence.

 

Better medicines for a fair price

Fair Medicine produces medicines according to a new business model, in which transparency and affordability come first. Fair Medicine founder Hans Büller thinks that physicians, patients and social investors ‘should work together’. 

 

Better medicines for a fair price

Fair Medicine produces medicines according to a new business model, in which transparency and affordability come first. Biologist Frans de Loos thinks is highly urgent that the ‘pharmaceutical industry gets a new stimulus’

FM works on Fair Patent

Fair Medicine wants Fair Patent to make the current patent system more transparent and open it up for smaller parties.

read more >>

Questions on sustainability of bio tech

Analyst of Goldman Sachs are asking serious questions on the sustainability of the bio tech model.

read more >>

India helps the poor with expensive drug

In India a mix of activists, government, doctors and local medicine products succeeded in lowering the price of sofosbuvir, a costly remedy for hepatitis C.

read more >>

Dutch Minister gets the spotlight

The new Minister of Health of the Netherlands, Bruno Bruins, came in guns blazing when he put the pharmaceutical industry on notice and announced on 22 November to “change the rules of the game” to tackle, what he called “absurd” medicines pricing

read more >>

Together we invest knowledge, time and money to produce better, safe and affordable medicines

Fair Medicine takes it differently than the classic pharmaceutical industry. We work with the coalition model. Patients, doctors, hospitals and pharmacists develop new resources together. Together we invest knowledge, time and money. And we’re transparent about the costs and what’s left at the end of the ride at acceptable profit. This enables us to access safe, effective and affordable medicines for everyone.